Hydrogen peroxide has long been known to damage cells and their DNA, but scientists have recently uncovered evidence that points to a more beneficial role: it appears to act as a signaling molecule in a critical cell pathway that stimulates cell growth, among other functions.
When that pathway goes awry, cells can grow out of control and become cancerous, so understanding hydrogen peroxide’s role could lead to new targets for potential cancer drugs, says Michael Strano, MIT associate professor of chemical engineering and leader of the research team. Strano and his colleagues describe their new sensor array, which is made of carbon nanotubes, in the March 7 online edition of Nature Nanotechnology.
Strano’s team is also working on carbon nanotube sensors for other molecules, and within the past year has successfully tested and published sensors for nitric oxide and ATP (the molecule that carries energy within a cell).
“The list of biomolecules that we can now detect very specifically and selectively is growing rapidly,” says Strano, who also points out that the ability to detect and count single molecules sets carbon nanotubes apart from many other nanosensor platforms, including electrochemical, electromechanical cantilevers and surface acoustic wave sensors.
In the new study, Strano’s team used the carbon nanotube array to study the flux of hydrogen peroxide that occurs when a common growth factor called EGF activates its target, a receptor known as EGFR, which is located on cell surfaces. For the first time, the team showed that hydrogen peroxide levels more than double when EGFR is activated.
EGF and other growth factors induce cells to grow or divide through a complex cascade of reactions inside the cell. It’s still unclear exactly how hydrogen peroxide affects this process, but Strano speculates that it may somehow amplify the EGFR signal, reinforcing the message to the cell. Because hydrogen peroxide is a small molecule that doesn’t diffuse far, the signal would be limited to the cell where it was produced.
The team also found that in skin cancer cells, believed to have overactive EGFR activity, the hydrogen peroxide flux was 10 times greater than in normal cells. Because of that dramatic difference, Strano believes this technology could be useful in building diagnostic devices for some types of cancer.
“You could envision a small handheld device, for example, which your doctor could use to assay tissue in a minimally invasive manner and tell if this pathway is corrupted,” he says.
The sensor consists of a film of carbon nanotubes embedded in collagen. Cells can grow on the collagen surface, and the collagen also attracts and traps hydrogen peroxide released by the cell. When the nanotubes come in contact with the trapped hydrogen peroxide, their fluorescence flickers. By counting the flickers, one can obtain an accurate count of the incident single molecules.
The new sensor represents “an excellent example of the application of nanotechnology to address fundamental questions in biology,” says Ravi Kane, professor of chemical and biological engineering at Rensselaer Polytechnic Institute.
Strano points out that this is the first time an array of sensors with single-molecule specificity has ever been demonstrated. He and his colleagues derived mathematically that such an array could distinguish “near field” molecular generation from that which takes place far from the sensor surface.
“Arrays of this type have the ability to distinguish, for example, if single molecules are coming from an enzyme located on the cell surface or from deep within the cell,” says Strano.
In future work, researchers in Strano’s lab plan to study different forms of the EGF receptor to better characterize the hydrogen peroxide flux and its role in cell signaling. They have already discovered that molecules of oxygen are consumed to generate the peroxide.